SCHEMBL891078

SCHEMBL891078

CC(C)(C)Cc1c[nH]cc1CC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.34
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24499204 0.70 RIPK1 (0.36) RIPK1
SCHEMBL22019448 0.67
SCHEMBL15978915 0.64 RIPK1 (0.32) RIPK1
SCHEMBL23862421 0.64
SCHEMBL13712515 0.64 HSPA5 (0.34)
SCHEMBL5962280 0.64 ESR1 (0.43) ESR1
SCHEMBL23788782 0.63 ESR1 (0.42) ESR1
SCHEMBL24419419 0.63 RIPK1 (0.38) RIPK1ESR1
SCHEMBL12672351 0.63 RIPK1 (0.38) RIPK1ESR1
SCHEMBL15943530 0.63 RIPK1 (0.33) RIPK1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US claimed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US claimed
EP-4359382-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS Chevron Phillips Chemical Company LP (US) 2024-05-01 EP disclosed
CN-117881658-A Two-step synthesis of pyrrole compounds from furan compounds 切弗朗菲利浦化学公司 2024-04-12 CN disclosed
US-11608317-B2 Two-step synthesis of pyrrole compounds from furan compounds CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2023-03-21 US disclosed
WO-2022197944-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2022-09-22 WO disclosed
US-20220298109-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2022-09-22 US disclosed
EP-2791091-B1 PREPARATION OF CHROMIUM(III) CARBOXYLATES CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-09-19 EP disclosed
US-9580453-B2 Preparation of transition metal carboxylates CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2017-02-28 US disclosed
US-20150105574-A1 Preparation of Transition Metal Carboxylates CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-04-16 US disclosed
US-8957235-B2 Preparation of transition metal carboxylates CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-02-17 US disclosed
EP-2791091-A1 PREPARATION OF TRANSITION METAL CARBOXYLATES Chevron Phillips Chemical Company LP (US) 2014-10-22 EP disclosed
WO-2013089963-A1 PREPARATION OF TRANSITION METAL CARBOXYLATES CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-06-20 WO disclosed
US-20130150593-A1 ANHYDROUS CHROMIUM(III) HALIDE COMPLEX PREPARATION CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-06-13 US disclosed
US-20130150605-A1 Preparation of Transition Metal Carboxylates CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-06-13 US disclosed
US-8450511-B1 Anhydrous chromium(III) halide complex preparation CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-05-28 US disclosed
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US disclosed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE PAH, CPS1, ASNS RIPK1 3811/4885ESR1 3887/4885
US-20130150593-A1 ANHYDROUS CHROMIUM(III) HALIDE COMPLEX PREPARATION CHD3, WNT3, CBX3 RIPK1 2872/4885ESR1 4086/4885
US-11608317-B2 Two-step synthesis of pyrrole compounds from furan compounds DDC, DHPS, ACMSD RIPK1 754/4885ESR1 3952/4885
US-20150105574-A1 Preparation of Transition Metal Carboxylates ACMSD, AP1M1, CA1 RIPK1 2237/4885ESR1 4145/4885
US-20130150605-A1 Preparation of Transition Metal Carboxylates ACMSD, AP1M1, CA1 RIPK1 2237/4885ESR1 4145/4885
US-20220298109-A1 TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS DDC, DHPS, ACMSD RIPK1 754/4885ESR1 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.